Literature DB >> 31074177

Pregenomic RNA: How to assist the management of chronic hepatitis B?

Yongbin Wu1, Jian Wen2, Weiwei Xiao3, Bao Zhang3.   

Abstract

Pregenomic RNA (pgRNA) is an emerging serological marker for chronic hepatitis B virus (HBV) infection. While pgRNA is principally the template for viral proteins and viral DNAs, additional novel functions for the serum pgRNA have recently been described. These results extend for pgRNA a regulatory function in the viral life cycle and potentially a role in pathogenesis. Here, we review the diverse roles of pgRNA in HBV replication and pathogenesis, emphasizing how the unique structure of this RNA is key to its various functions. We focus in particular on the role of HBV pgRNA in guiding antiviral therapy including nucleot(s)ide analog interruption and role as a marker of cure with new curative therapies. We also briefly allude to the emerging niche for new direct-acting or indirect-acting antivirals targeting pgRNA.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  antiviral therapy; chronic hepatitis B; hepatitis B virus; marker; pregenomic RNA

Mesh:

Substances:

Year:  2019        PMID: 31074177     DOI: 10.1002/rmv.2051

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  5 in total

1.  Diagnostic Value of Detection of Pregenomic RNA in Sera of Hepatitis B Virus-Infected Patients with Different Clinical Outcomes.

Authors:  Ni Lin; Aizhu Ye; Jinpiao Lin; Can Liu; Jinlan Huang; Ya Fu; Songhang Wu; Siyi Xu; Long Wang; Qishui Ou
Journal:  J Clin Microbiol       Date:  2020-01-28       Impact factor: 5.948

2.  Serum Hepatitis B Virus RNA Levels Predict HBeAg Seroconversion and Virological Response in Chronic Hepatitis B Patients with High Viral Load Treated with Nucleos(t)ide Analog.

Authors:  Xin Ji; Muye Xia; Bin Zhou; Shi Liu; GuiChan Liao; Shaohang Cai; Xiaoyong Zhang; Jie Peng
Journal:  Infect Drug Resist       Date:  2020-06-22       Impact factor: 4.003

3.  Dynamics of Serum Pregenome RNA in Chronic Hepatitis B Patients Receiving 96-Month Nucleos(t)ide Analog Therapy.

Authors:  Yachao Tao; Menglan Wang; Juan Liao; Xing Cheng; Min He; Dongmei Zhang; Taoyou Zhou; Jie Chen; Enqiang Chen; Hong Tang
Journal:  Front Med (Lausanne)       Date:  2022-02-28

4.  Clinical Implications of Serum Hepatitis B Virus Pregenomic RNA Kinetics in Chronic Hepatitis B Patients Receiving Antiviral Treatment and Those Achieving HBsAg Loss.

Authors:  I-Chin Wu; Wen-Chun Liu; Yen-Cheng Chiu; Hung-Chih Chiu; Pin-Nan Cheng; Ting-Tsung Chang
Journal:  Microorganisms       Date:  2021-05-26

Review 5.  Molecular Mechanisms during Hepatitis B Infection and the Effects of the Virus Variability.

Authors:  Marina Campos-Valdez; Hugo C Monroy-Ramírez; Juan Armendáriz-Borunda; Laura V Sánchez-Orozco
Journal:  Viruses       Date:  2021-06-18       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.